Middle East and Africa Insulin Infusion Pumps Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Middle East and Africa Insulin Infusion Pumps Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Middle East and African Insulin Infusion Pumps Market is expected to register a CAGR of more than 5% during the forecast period of 2022-2027. The market is estimated to reach a value of more than USD 47 million by 2027.

The COVID-19 pandemic positively impacted the Insulin Infusion Pumps market growth in the Middle East and African region. Patients with diabetes, infected with SARS-CoV-2 experience additional stress and increased secretion of hyperglycemic hormones, which results in elevated blood glucose, abnormal glucose variability, and diabetic complications. Diabetes and uncontrolled hyperglycemia are risk factors for poor outcomes in patients with COVID-19 including an increased risk of severe illness or death. To avoid complications, a patient's blood glucose level should be maintained at a normal level. The manufacturers of Insulin Infusion Pumps have taken care during COVID-19 to deliver the insulin delivery devices to diabetes patients with the help of local governments.

An insulin infusion pump works as an alternative to the traditional system of daily injections or an insulin pen. Insulin infusion pumps reduce the large swings in blood glucose level, lessen pain, and deliver more accurately than injections. The scheduling of meal timings is not required when using pumps. This makes infusion pumps more user-friendly for patients. Insulin therapy is also known as continuous subcutaneous insulin infusion (CSII). It is an efficient and flexible method of insulin delivery.

73 million adults (20-79) are living with diabetes in the IDF MENA Region in 2021. This figure is estimated to increase to 95 million by 2030. 48 million adults in the IDF MENA Region are living with Impaired Glucose Tolerance, which places them at increased risk of developing type 2 diabetes. Diabetes is responsible for 796,000 deaths in the IDF MENA Region in 2021. USD 33 billion was spent on healthcare for people with diabetes in 2021.

Technological advancements have increased over the period in Insulin delivery devices for safer and more accurate administration of insulin. In 2021, Medtronic launched an Extended infusion set that leverages advanced materials that help reduce insulin preservative loss and maintains insulin flow and stability. The set is compatible with all MiniMed™ 600 and 700 series insulin pumps. The new tubing connector improves the physical and chemical stability of insulin, reliability of infusion site performance, and reduces the risk of infusion set occlusion.

Diabetes is associated with many health complications. Patients with diabetes require many corrections throughout the day to maintain nominal blood glucose levels, such as administering additional insulin or ingesting additional carbohydrates by monitoring their blood glucose levels. Diabetes poses an emerging healthcare burden across the region.

Owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Key Market TrendsInsulin Pump Device Hold Highest Market Share 2021

Insulin Pump Device held more than 54% market share in the insulin infusion pumps market in 2021 and is expected to grow with a CAGR of around 5% in the market during the forecast period because of the increasing technological advancement and its preference over other traditional methods due to continuous insulin administration.

An insulin pump is a device, which delivers insulin continuously or whenever required automatically. The pump mimics the human pancreas. The insulin infusion pump works as an alternative to the traditional system of daily injections or an insulin pen. Insulin pump therapy is a well-established insulin administration method for type 1 diabetes (T1DM) people. Pumps are a validated, time-tested therapeutic option in T1DM at all ages, enabling near-physiological insulin delivery in situations where the pancreas does not produce insulin.

There are even pump models with remote controls enabling parents of young children to either suspend or bolus insulin from a distance when the child is playing or eating.​ The insulin infusion pumps reduce the large swings in blood glucose level, induce less pain, and deliver more accurately when compared to injections. The use of continuous subcutaneous insulin infusion (CSII or insulin pumps) and continuous glucose monitoring systems (CGMs) has improved the care and quality of life for patients and is widely used in the ambulatory setting. Increasingly, this technology is also being used in the hospital setting. These advantages of insulin pumps over the traditional delivery system are expected to boost the market.

The Middle East and African region had witnessed an alarming increase in the prevalence of diabetes, in recent years, the rate of diabetes is at an all-time high, mainly due to lifestyle changes. Governments in the ME have identified the threat of diabetes and started to respond with various policies, initiatives, and programs. Six out of 15 countries in this region still do not have a national operational action policy for diabetes. Many countries still do not have a national strategy to reduce overweight, obesity, and physical inactivity, which are important risk factors for diabetes. Most counties have fully implemented national diabetes treatment guidelines. However, constant measures are being taken to minimize diabetic complications therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the Middle East and African region.

Egypt is Expected to Dominate the Middle East and Africa Insulin Infusion Pumps Market

Egypt is expected to register a CAGR of over 4.5% between 2022 and 2027.

Egypt is the ninth country in terms of Diabetes prevalence worldwide. Currently, as per IDF, about 18.4% of the adult population in Egypt has diabetes. Due to the adaptability of new technology and the high prevalence of diabetes, Egypt dominates the market, among other countries. It is imperative that the CGM devices be used alongside insulin pumps. As the trends show a higher number of diabetic patients moving to CGM for diabetes monitoring, it can be predicted that the number of units of insulin infusion pump devices sold will also follow. The insulin pump has evolved and is more reliable than it was previously. CSII technology has witnessed numerous technological advancements, like the integration of continuous glucose monitoring with the pump. Now, insulin pumps can control the algorithm that automatically delivers the insulin, after analyzing the blood glucose reading. Type-1 patients require monitored insulin dosage for maintaining normal glucose levels which is likely to generate demand in the coming years.

In Egypt, the social level plays an important role in patients’ access to health care as the number of health care centers, hospitals, and pharmacies is very low in rural areas compared to big cities and urban areas. The financial level is a major determinant of people’s access to health care as the salaries of most of the employees in Egypt are not enough to afford their monthly diabetes supplies. Insulin pumps are neither present nor covered by health insurance in Egypt. For students and school children with type 1 diabetes, the National Health Insurance System covers insulin, and the student pays nothing for NPH, mixed and short-acting insulins, and only 60% of the price of other types of insulin which are usually not available in the pharmacies of the National Health Insurance System.

However, there is a growing demand for quality healthcare services in Egypt spurred by changes including an increasing and aging population, and a growing prevalence of lifestyle diseases. The government and private sector are both involved to work on healthcare entities and ensuring affordability, access, and quality primary care.

Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in Egypt.

Competitive Landscape

The Middle East and African Insulin Infusion Pumps market is consolidated, with few major manufacturers present in the market. The Insulin Infusion Pumps devices market is dominated by a few major players, like Becton Dickinson, Medtronics, Ypsomed, and Insulet.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.